Trial intelligence / Profile preview

Omega-3 polyunsaturated fatty acids during chemotherapy in lung cancer

2006-002978-21Phase 3Active

Sponsor
AOU Città della Salute e della Scienza di Torino
Start
Jul 2007
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of omega-3-acid triglycerides in bronchial carcinoma and cancer anorexia-cachexia syndrome (CACS), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: Chemotherapy failure due to intolerance/toxicity. Started Jul 2007; status: active.

02

Drugs

omega-3-acid triglycerides
03

Conditions

bronchial carcinomacancer anorexia-cachexia syndrome (CACS)

Beyond the preview

Go deeper on 2006-002978-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002978-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call